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Introduction. Obesity is increasingly common and is associated with an increased prevalence of cardiac arrhythmias. The aim of
this study was to see whether in obesity there is proarrhythmic gene expression of ventricular ion channels and related molecules.
Methods and Results. Rats were fed on a high-fat diet and compared to control rats on a normal diet (𝑛 = 8). After 8 weeks, rats
on the high-fat diet showed significantly greater weight gain and higher adiposity. Left ventricle samples were removed at 8 weeks
and mRNA expression of ion channels and other molecules was measured using qPCR. Obese rats had significant upregulation of
Cav1.2, HCN4, Kir2.1, RYR2, NCX1, SERCA2a, and RYR2 mRNA and downregulation of ERGmRNA. In the case of HCN4, it was
confirmed that there was a significant increase in protein expression.The potential effects of the mRNA changes on the ventricular
action potential and intracellular Ca2+ transient were predicted using computer modelling. Modelling predicted prolongation
of the ventricular action potential and an increase in the intracellular Ca2+ transient, both of which would be expected to be
arrhythmogenic. Conclusion. High-fat diet causing obesity results in arrhythmogenic cardiac gene expression of ion channels and
related molecules.
1. Introduction
Obesity is an important developing health issue worldwide
and the percentage of people classified as obese (BMI >
30 kg/m2) has more than doubled in the last half century [1],
which has significant potential consequences for the car-
diovascular health of the population. The process by which
individuals become obese is a multifactorial one with con-
sumption of a diet with an excessive energy content arising
mainly from high levels of refined carbohydrates and satu-
rated fats, combined with a reduced level of physical activity,
a common observation in epidemiological studies [2].While,
in a heterogeneous population, obese individuals will vary in
whether their diet contains a higher proportion of saturated
fats or refined carbohydrates, there are many studies report-
ing that diets rich in saturated fats lead to obesity [3].
Obesity is linked to an increased likelihood of atrial [4]
and ventricular [5] arrhythmias and sudden cardiac death [6].
The mechanisms responsible for the increase in arrhythmias
are not understood. In obese individuals who succumbed
to sudden cardiac death, an increase in ventricular ectopy
has been observed, which in many cardiac disease states is
linked to prolonged ventricular arrhythmias and death [7].
An increase in the corrected QT interval in obese individuals
has been observed [8] and an increase in the QT interval is
a common finding in many arrhythmogenic disorders. The
increase in the QT interval has been suggested to be the
result of high levels of circulating fatty acids interfering with
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Table 1
Ingredient Control diet High-fat diet
Grams Kcal Grams Kcal
Casein 80 Mesh 200 800 200 800
L-Cystine 3 12 3 12
Corn starch 510 2040 208 820
Maltodextrin 10 90 360 90 360
Sucrose 100 400 100 400
Cellulose 50 0 50 0
Soybean oil 25 225 25 225
Lard 20 180 155.5 1400
tBHQ 0.038 0 0.031 0
Mineral mix 10 0 10 0
Dicalcium phosphate 13 0 13 0
Calcium carbonate 5.5 0 5.5 0
Potassium citrate 16.5 0 16.5 0
Vitamin mix 10 40 10 40
Chlorine bitartrate 2 0 2 0
Food dyes 0.05 0 0.05 0
Total 1055.9 4057 885.58 4057
ventricular repolarization [9]. However, the increase in the
QT interval could also be the result of changes in ventricular
ion channel expression. For example, in heart failure, there
are changes in ventricular ion channel expression and an
increase in the QT interval and ventricular arrhythmias [10].
The rationale behind this study is as follows: in light of
the rapidly increasing number of obese patients in many
countries, there is a lack of data on the potential mech-
anisms for the higher rates of arrhythmias seen in obese
patients when compared to other conditions associated with
arrhythmias such as channelopathies where mechanisms
are well researched and understood. The objective of this
study as part of a wider study into the effects of dietary
obesity was to gain an insight into some of the potential
mechanisms underlying obesity-induced arrhythmogenesis
by investigating the expression of a variety of key cardiac ion
channels (and related molecules) in a rat model of obesity
based on high saturated fat consumption.
2. Methods
2.1. Animals and Diets. Age-matched male Wistar rats
(∼250 g; Charles River, Margate, UK) were arbitrarily
assigned into two groups and fed with either a high-fat diet
(HFD) or control diet for eight weeks (𝑛 = 8/group). These
provided either 40% of calories (high-fat diet) or 10% of
calories (control diet) from saturated fatty acids (sourced
mainly from lard) or polyunsaturated fatty acids (sourced
mainly from soybean oil), respectively.The rest of the diet was
made up of 20% protein in both groups and the remaining
calories were carbohydrates mainly from corn starch
(Research Diets, Inc., New Brunswick, NJ, USA). Both diets
contained equal amounts of the antioxidant tert-butylhydro-
quinone (tBHQ) to preserve the component fats. Compara-
tive diet compositions per feed batch are shown in Table 1.
All animals were singly housed,maintained on a standard
12-hour on/off light cycle, and provided with food and water
ad libitum. Body weight was measured weekly and food
intake daily. After eight weeks, all animals were killed with
a rising concentration of carbon dioxide, followed by cervical
dislocation. A single epididymal fat pad was then dissected
from each rat and weighed. As a measure of adiposity, this
mass was later expressed relative to the final body weight,
as previously described [11]. Hearts were dissected from all
rats and placed in physiological Hartmann’s solution, where
standard anatomical markers were used as reference points
before removing a 5mm strip of the midleft ventricular
free wall, which was snap-frozen in liquid N
2
(−80∘C). All
experiments were undertaken in accordance with the UK
Animals (Scientific Procedures) Act 1986.
2.2. RNA Isolation andQuantitative Gene Expression Profiling.
Frozen tissue was subsequently cut into 20𝜇m sections on a
cryostat before RNAwas isolated using Qiagen RNeasymini-
columns (Qiagen, Crawley, UK). RNA quality was assessed
using commercially available spectrophotometry (Nanodrop,
Thermo Scientific, Loughborough, UK) and an equal amount
of RNA from each sample was then amplified to cDNA
using high-capacity RNA to cDNA for quantitative PCR
(Applied Biosystems, Warrington, UK). Quantitative PCR
was performed using custom preloaded low-density TaqMan
array microfluidic cards, Universal Mastermix II, and a
7900HT fast real-time PCR system (Applied Biosystems).
Relative expression of the gene targets was made using the
“ΔCt method,” in which the abundance of target genes is
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normalised to the abundance of a housekeeper (or reference)
gene, 18-s in this study. 18-s was chosen as the housekeeper
after an analysis of several potential housekeeper genes (18-s,
GAPDH, andCx43) as it had the smallest𝑀 value, as assessed
by geNORM analysis [12] (StatMiner 4.1, Integromics, Uck-
field, UK).
Relative abundance of mRNA is presented in arbitrary
units referenced to 18-s expression for all gene targets.
2.3. Immunofluorescence. In the case of HCN4, protein
expression was measured using immunofluorescence with
quantitative signal intensity as described previously [13, 14].
Frozen sections of the midleft ventricular free wall that
previously had been isolated (𝑛 = 8/group) were placed on
a cryostat and 10 𝜇m thick sections sectioned and placed on a
Poly-Prep slide (Sigma-Aldrich, Dorset, UK). Sections were
fixed in buffered 10% formalin solution and sections were
then washed in 1x phosphate buffered saline (PBS) before
permeabilisation with 0.1% Triton-X 100 before nonspecific
blocking with bovine serum albumin (BSA) diluted in PBS.
Sections were then incubated overnight at 4∘C in the dark
with 1 : 100 primary antibody (rabbit anti-HCN4, Alomone,
Jerusalem, Israel) in 1% BSA in PBS before washing with PBS
and incubation in the dark at room temperature with 1 : 500
secondary antibody (donkey anti-rabbit IgG, rhodamine,
Millipore, Watford, UK) in 1% BSA in PBS for 2 h. A
negative control was undertaken using a section from a
control animal incubated with secondary antibody but not
primary antibody: no labelling was observed (in keeping
with other studies from our group [15, 16]). Sections were
then washed with PBS before mounting with Vectashield
(Vectorlabs, Peterborough, UK). Confocal microscopy (Zeiss
LSM5 PASCAL, Zeiss, Cambridge, UK) was used for image
acquisition before quantitative immunofluorescence signal
intensity measurements were carried out using Volocity
software (PerkinElmer, Beaconsfield, UK). For each sample,
5 regions of the left ventricular cryostat sample were analysed
with an identical field of view size and the signal intensity
value was recorded before being averaged.
2.4. Mathematical Modelling of the Action Potential. Before
specific modelling of the funny current (𝐼
𝑓
), the original
model in Pandit et al. [17] was modified to incorporate
experimental data from Cerbai et al. [18] more specifically.
Further details are available in the supplementary data. The
activation curve from Cerbai et al. [18] was fitted using the
Boltzmann distribution (𝑉
𝐻
= −87.74mV, 𝑘 = −10.12):
𝑦∞ =
1.0
1.0 + 𝑒
(𝑉+87.74)/10.12
, (1)
where 𝑦∞ is the steady-state value of the activation variable,
𝑦, and 𝑉 is the membrane potential. The time constant of 𝐼
𝑓
activation was reformulated based on data from Cerbai et al.
[18]:
𝜏
𝑦
=
1.0
0.1177 ∗ 𝑒
(𝑉+86.78)/29.5
+ 08141 ∗ 𝑒
−(𝑉+86.78)/14.75
, (2)
Table 2: Simulated changes in current density based on the mRNA
expression differences shown in Figures 1–3.
Channel Current High fat
Nav1.5 𝐼Na +163.60%
Cav1.2 𝐼Ca,L +441.28%
Kv1.4, Kv4.2, and Kv4.3 𝐼to +240.45%
Kv1.5 𝐼K,ss +232.73%
HCN4 𝐼
𝑓
+222%
Kir2.1 𝐼K,1 +233.83%
NCX1 𝐼NaCa +290.10%
SERCA2a SR Ca2+ uptake +139%
RYR2 SR Ca2+ release +253.97%
ATP1𝛼1-3 𝐼NaK 251%
where 𝜏
𝑦
is the time constant of 𝑦. The rate of change in the
activation variable, 𝑦, was calculated from
𝑑𝑦
𝑑𝑡
=
𝑦∞ − 𝑦
𝜏
𝑦
. (3)
Finally, 𝐼
𝑓
was calculated assuming that it is carried by a
mixture of Na+ and K+:
𝐼
𝑓
= 𝑔
𝑓
𝑦 [𝑓Na (𝑉 − 𝐸Na) + 𝑓K (𝑉 − 𝐸K)] , (4)
where 𝑔
𝑓
is the maximum conductance, 𝑓Na and 𝑓K are the
fractions of 𝐼
𝑓
carried byNa+andK+ (𝑓Na = 0.2;𝑓K = 1−𝑓Na),
and 𝐸Na and 𝐸K are the equilibrium potentials of Na
+and K+.
𝑔
𝑓
(0.0043 𝜇S) was obtained by matching simulated current
traces of 𝐼
𝑓
to experimental data.
In normal and obesity conditions, the models were run
for a 5 s period to obtain a stable state condition before
a sequence of external stimulus pulses (with an amplitude
of 0.8 nA, duration of 6ms, and frequency of 1Hz) were
applied to evoke an action potential. In order to evaluate
the relative role of each of the remodelled ionic currents,
simulations were also performed by considering changes to
each individual ionic current alone.
To simulate the effects of obesity, the channel conduc-
tance for each of the presumed remodelled ionic currents
in Pandit et al.’s model [17] was scaled according to the
measured average percentage change of the corresponding
mRNA between the control and high-fat diet groups. Using
this mRNA change, the original baseline equation variables
were altered for the high-fat diet group before the model was
run to produce an action potential as described previously
[19, 20]. No changes were made to ion concentrations in the
calculations.
A summary of the relative expression differences in
the high-fat group used to produce the modelled action
potentials is shown in Table 2.
2.5. Statistical Analysis. Grouped mean data are reported as
mean ± SEM. Between-group comparisons were made using
Student’s 𝑡-test if a Shapiro-Wilk test of normality was passed
or a rank sum test if the data was not normally distributed.
Results were considered significant when 𝑃 < 0.05.
4 Journal of Obesity
 ERG  KChIP2
Control group
HFD group
Control group
HFD group
Control group
HFD group
Nav1.5 (Scn5a) Cav1.2 (Cacna1c) Kv1.4 (Kcna4)
Kv1.5 (Kcna5) Kv4.2 (Kcnd2) Kv4.3 (Kcnd3)
∗
∗∗
KvLQT1 (Kcnq1)
0.00000
0.00005
0.00010
0.00015
0.00020
0.00025
m
RN
A
 ex
pr
es
sio
n
0.0000
0.0001
0.0002
0.0003
0.0004
0.0005
0.0006
m
RN
A
 ex
pr
es
sio
n
0.000
0.001
0.002
0.003
0.004
0.005
0.006
m
RN
A
 ex
pr
es
sio
n
0.0000
0.0002
0.0004
0.0006
0.0008
m
RN
A
 ex
pr
es
sio
n
0.000
0.005
0.010
0.015
0.020
0.025
m
RN
A
 ex
pr
es
sio
n
0.00000
0.00005
0.00010
0.00015
0.00020
0.00025
0.00030
m
RN
A
 ex
pr
es
sio
n
0.00000
0.00002
0.00004
0.00006
0.00008
0.00010
m
RN
A
 ex
pr
es
sio
n
0.0000
0.0002
0.0004
0.0006
0.0008
0.0010
0.0012
0.0014
m
RN
A
 ex
pr
es
sio
n
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
m
RN
A
 ex
pr
es
sio
n
Figure 1: Normalised to 18-s expression of mRNA for major ion channels active during the action potential in the left ventricle of the control
and obesity groups in arbitrary units referenced to the housekeeper gene 18-s. Means ± SEM shown (𝑛 = 8/group). ∗Significantly different
from the control group (𝑃 < 0.05). ∗∗Significantly different from the control group (𝑃 < 0.01).
3. Results
3.1. Dietary Outcomes. Over the course of the study, high-fat-
diet-fed rats consumed more energy (28.1 ± 1.0 × 103 versus
23.7±0.9 × 103 kJ; +18%,𝑃 = 0.02 versus controls) and gained
more weight (232.9 ± 12.4 versus 308.6 ± 18.5; +32%; 𝑃 <
0.01) than did control animals. The latter was consistent
with greater accrual of adipose tissue in high-fat-diet-fed rats
(+1.449% ± 0.010 versus 1.032 ± 0.08; +40%; 𝑃 < 0.01). Due
to the high energy content of the high-fat diet, lesser intake
was required to induce weight gain in this group compared to
controls (−10%; 𝑃 = 0.02).
3.2. Transcriptome of Major Ion Channels Active during
the Action Potential. Expression of ion channels in the left
ventricle of the obese rats (𝑛 = 8) wasmeasured at themRNA
level using quantitative PCR and compared to that in the
control lean rats (𝑛 = 8). Expression of the principal Na+
channel, Nav1.5 (Scn5a), responsible for the Na
+ current (𝐼Na)
tended to be greater in the obese group, but not significantly
so (Figure 1). However, expression of the principle L-type
Ca2+ channel, Cav1.2 (Cacna1c), responsible for the L-type
Ca2+ current (𝐼Ca,L) was significantly increased in the obese
group with an increase greater than 500% (𝑃 < 0.01).
Expression of Kv1.4 (Kcna4), Kv4.2 (Kcnd2), Kv4.3 (Kcnd3),
and KChIP2 (Kcnip2), responsible for the transient outward
K+ current (𝐼to), Kv1.5 (Kcna5), responsible for the ultrarapid
delayed rectifier K+ current (𝐼K,ur) in humans but the steady-
state current (𝐼K,ss) in rats, and KvLQT1 (Kcnq1), responsible
for the slow delayed rectifier K+ current (𝐼K,s), all tended to
be greater in the obese group, but not significantly so. In
contrast, expression of ERG (Kv11.1), responsible for the rapid
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Figure 2: Normalised to 18-s expression of mRNA for major ion channels active largely during diastole in the left ventricle of the control and
obesity groups in arbitrary units referenced to the housekeeper gene 18-s. Means ± SEM shown (𝑛 = 8/group). ∗Significantly different from
the control group (𝑃 < 0.05).
delayed rectifier K+ current (𝐼K,𝑟), was significantly decreased
in the obese group (𝑃 = 0.029, as shown in Figure 1).
3.3. Transcriptome of Major Ion Channels Active during
Diastole. Three channel isoforms, HCN1, HCN2, andHCN4,
are responsible for the funny current (𝐼
𝑓
), an important pace-
maker current. Expression of all three isoforms tended to be
greater in the obese group but the increase in HCN4 (322%)
was significant (𝑃 = 0.03). In the obese group, there was
significantly increased expression of Kir2.1 (Kcnj2) respon-
sible for the background inward rectifier K+ current (𝐼K,1,
Figure 2). Expression of Kir3.1 (Kcnj3) and Kir3.4 (Kcnj5)
responsible for the ACh-activated K+ current (𝐼K,ACh) tended
to be greater in the obese group, but not significantly so
(Figure 2). There was a nonsignificant increase in the expres-
sion of the Na+-K+ATPases 1–3.
3.4. Transcriptome of Intracellular Ca2+-Handling Molecules.
Intracellular Ca2+ plays an important role in arrhythmogene-
sis and three important intracellular Ca2+-handling mole-
cules were investigated: NCX1 (the Na+-Ca2+exchanger),
SERCA2a (ATP2a2, the sarcoplasmic reticulum (SR) Ca2+
pump), and RYR2 (the ryanodine receptor, the SR Ca2+
release channel). Expression of all three was significantly
increased in the obese group (Figure 3) by over 200% for
NCX1 and RYR2 (𝑃 < 0.01).
3.5. Immunolabelling of HCN4. In the case of the pacemaker
ion channel, HCN4, immunohistochemistry was used to
show whether the mRNA changes led to corresponding
changes at the protein expression level. Signal intensity mea-
surements of HCN4 protein expression support the notion
that increased mRNA expression was associated with higher
protein expression (𝑃 < 0.01) (Figure 4).
3.6. Potential Effect of Obesity on the Ventricular Action
Potential as Predicted by Action Potential Modelling. Figure 5
shows simulated action potentials (top row) of rat endo-
cardial (Figure 5(a)) and epicardial (Figure 5(b)) ventricular
cells in control and obesity conditions, accompanied by
underlying ionic currents and the intracellular Ca2+ con-
centration. In both cell models, remodelled ion channels
in the obesity condition produced increased amplitude of
the action potential, elevation in the plateau phase, and an
increase in the action potential duration (Figure 5). Notably,
there was a pronounced slow tail of repolarization following
the action potential; slow tails of repolarization following
the rat ventricular action potential have been reported in
experiments [21]. In the obesity condition, simulation results
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Figure 3: Normalised to 18-s expression of mRNA for major Ca2+-handling molecules in the left ventricle of the control and obesity groups
in arbitrary units referenced to the housekeeper gene 18-s. Means ± SEM shown (𝑛 = 8/group). ∗Significantly different from the control group
(𝑃 < 0.05). ∗∗Significantly different from the control group (𝑃 < 0.01).
also showed that the amplitude of the intracellular Ca2+
concentration was increased (Figure 5).
3.7. Effects of Each of the Remodelled Ion Channels on the
Ventricular Action Potential. Potential effects of each of the
remodelled ion channels on the ventricular action potential
were investigated. Results are shown in Figure 6. The poten-
tial increase in 𝐼Ca,L alone produced a dramatic increase in the
duration of the plateau phase, leading to a failure of repolar-
ization; consequentially, the models failed to produce a full
action potential (Figure 6(a)). The potential increase in 𝐼to
alone abbreviated the action potential and reduced the action
potential amplitude (Figure 6(c)). The potential increases in
𝐼K,ss (Figure 6(e)) and 𝐼K,1 (Figure 6(f)) resulted in small
abbreviations of the action potential. Upregulation of 𝐼NaCa
(Figure 6(g)) resulted in a small delay in phase 3 repolariza-
tion.
Therefore, the simulations suggest that the obesity-
induced changes in ion channels could result in prolongation
of action potential primarily as a result of an increase in 𝐼Ca,L,
the effects of which are offset to a degree by increases in 𝐼to
and 𝐼K,1.
4. Discussion
We have shown that a diet rich in saturated fats leading to
obesity results in significant upregulation of Cav1.2, HCN4,
Kir2.1, NCX1, SERCA2a, and RYR2 mRNA and significant
downregulation of ERG mRNA in the left ventricle. mRNA
changes when modelled caused significant abnormalities
in the modelled action potential. Such changes may help
define the substrate underlying obesity-induced ventricular
arrhythmias.
4.1. Channels and Exchanger Proteins. The upregulation of
Cav1.2 mRNA in obesity (Figure 1), if translated into an
increase in 𝐼Ca,L, is expected to be proarrhythmic. Action
potential modelling (Figure 6(a)) showed that an increase
in Cav1.2 and 𝐼Ca,L will lead to prolongation of phase 2 of
the action potential and the QT interval. It is also expected
to directly and indirectly promote the formation of early
and delayed afterdepolarizations (EADs and DADs), which
can generate ectopic beats and arrhythmias [22]. The action
potential modelling showed a large increase in Na+-Ca2+
exchange current, 𝐼NaCa (Figure 5). Figure 6(g) suggests that
the effect of an increase in 𝐼NaCa simply as a result of the upreg-
ulation ofNCX1mRNA is small; however, Figure 6 shows that
the large Ca2+ transient helps to create a large 𝐼NaCa current.
In obesity, it is predicted that 𝐼NaCa is a large inward current in
diastole immediately after the action potential and it declines
slowly as intracellular Ca2+ falls. The large inward 𝐼NaCa
generates a slow tail of repolarization after the action poten-
tial (Figure 6(g)). In cardiac hypertrophy and heart failure,
upregulation of NCX1 has been repeatedly described [23].
There was upregulation of Kir2.1 mRNA (responsible for 𝐼K,1)
in obesity (Figure 2). Overexpression of Kir2.1 and increase of
𝐼K,1 result in acceleration of the final phase of repolarization
and a shorter action potential [24]. This is confirmed by
the action potential modelling in Figure 6(f). An increase in
𝐼K,1 is also reported to cause an increase in the transmural
dispersion of repolarization [25], facilitating reentry arrhyth-
mias [26]. The upregulation of Kir2.1 (𝐼K,1) may be compen-
satory to prevent incomplete repolarization and minimise
prolongation of the action potential caused by the upreg-
ulation of Cav1.2 (and 𝐼Ca,L, Figure 6(a)). There was down-
regulation of ERG mRNA (responsible for 𝐼K,𝑟) in obesity
(Figure 2). In the rat ventricle, ERG and 𝐼K,𝑟 are not thought
to be functionally important; however, in the human, reduced
expression or drug blockade of ERG and 𝐼K,𝑟 is a well-known
cause of action potential/QT prolongation and ventricular
arrhythmias [27].
We observed significant upregulation in HCN4 at the
mRNAand protein levels (Figures 3 and 5) in the left ventricle
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Figure 4: Representative images of HCN4 immunolabelling (white signal) in the left ventricle of control (a) and obese (b) animals. (c) Mean
± SEM signal intensity in arbitrary units of HCN4 immunolabelling in the left ventricle of the control and obesity groups (𝑛 = 8/group).
∗∗Significantly different from the control group (𝑃 < 0.01).
in obesity, a key pacemaker channel. HCN channels are
expressed in the working myocardium, but at a lower level
than in the cardiac conduction system [28]. Upregulation
of HCN4 has been observed in the ventricles of rats with
hypertrophy resulting from pressure overload [29] and left
ventricular hypertrophy is a common finding in obese indi-
viduals [30]. HCN4 protein levels in the sinus node and the
total area of HCN4 expressing tissue within the sinus node
have been shown to be increased in elderly obese rats [31].
In a postmyocardial infarction animal model, ventricular
upregulation of HCN4 causes a high volume of ventricular
ectopic beats and potentially prolonged ventricular arrhyth-
mias [32]. In contrast, action potential modelling suggested
that upregulation of HCN4 (and 𝐼
𝑓
) has no effect on the rat
ventricular action potential (Figure 6(h)).
In summary, the increase in the QT interval observed
in clinically obese patients [8] may be due to increased 𝐼Ca,L
predominantly.
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Figure 5: Simulated rat ventricular endocardial ((a) ENDO) and epicardial ((b) EPI) action potentials and underlying ionic currents and
intracellular Ca2+ concentration in control and obesity conditions.
4.2. Ca2+-Handling Proteins. There was upregulation of
SERCA2amRNA (responsible for the SR Ca2+ pump) in obe-
sity (Figure 3). Upregulation of mRNA for SERCA2a and the
closely associated molecule, phospholamban, has previously
been reported in obese rats [33]. The increased SERCA2a
expression has previously been explained as a response to
oxidative damage to the SR caused by excess free radical
generation in obesity [34]. The upregulation of SERCA2a is
expected to increase the level of Ca2+ in the SR and an
increase in 𝐼Ca,L in obesity is expected to have the same effect.
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Figure 6: Simulated rat ventricular endocardial and epicardial action potentials in control and obesity conditionswhen each of the remodelled
ion channels/ionic currents was modified one at a time. (a) Only 𝐼Ca,L considered. (b) Only 𝐼Na considered. (c) Only 𝐼to considered. (d) Only
𝐼NaK considered. (e) Only 𝐼ss considered. (f) Only 𝐼K,1 considered. (g) Only 𝐼NaCa considered. (h) Only 𝐼𝑓 considered. (i) Only SR Ca
2+ uptake
and release considered (𝐽Up and 𝐽Rel, resp.).
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Such an increase in the level of Ca2+ in the SR is expected
to result in an increase in the intracellular Ca2+ transient
and this is consistent with the predictions of the computer
simulations (Figure 6). Several studies have suggested that
increased SERCA2a activity leading to Ca2+ overload in the
SR can lead to abnormal SR Ca2+ release and DADs leading
to arrhythmias [35] although other work has shown increased
SERCA2a to be antiarrhythmogenic [36]. In the early stages
of left ventricular hypertrophy, SERCA2a has previously been
shown to be upregulated [37]. There was upregulation of
RYR2mRNA (responsible for the SR Ca2+ release channel) in
obesity (Figure 3). Together with the upregulation of Cav1.2
and SERCA2a, this is expected to be the cause of the increase
in the intracellular Ca2+ transient (Figure 6). Some of the
respective increase observed in SERCA2a and NCX1 we have
seenmay be a response to the increase in RYR2 and the intra-
cellular Ca2+ transient [38] and this may be compensatory to
remove excess Ca2+ from the sarcoplasmic reticulum which
can be caused by leak from RYR2 but further work would be
needed to confirm this.
4.3. Overall Phenotype. The overall phenotype we had mod-
elled here and as would be expected from themRNA changes
is to cause prolongation of the action potential with an
increase in the plateau phase followed by a sharper phase
3 repolarisation slope. Clinically, this prolongation of the
action potential would lead to QT prolongation which is very
closely linked to clinical arrhythmias. Some of the changes
we saw had conflicting effects on the AP with Kir2.1 (𝐼K,1) in
particular likely to be compensatory to some of the AP pro-
longation caused predominantly by Cav1.2 and 𝐼Ca,L. Whilst
we did not see a statistical difference in mRNA expression
for the genes encoding the 𝐼to current, the tendency for these
to be increased would be a natural compensation to the
increased Cav1.2 and 𝐼Ca,L and would try to abbreviate the
increase in the plateau phase and action potential duration.
Overall, while there were some gene changes that appear to
oppose the proarrhythmic effect of others, the predominant
modelled phenotype was arrhythmogenic with prolongation
of the AP.
4.4. Limitations. This study has primarily been an explor-
atory study identifying areas of interest in what we believed
to be an underresearched area but as with all studies there are
limitations to the data presented here. The major limitation
of this study is a lack of direct protein quantification to
correlate with our mRNA results and then subsequently
direct electrophysiological testing of the channels (assessed
at an mRNA level here). Whilst the TaqMan system has been
used with reproducible results by our group and others, the
mRNA data we present cannot be said to be evidence of a
protein level change or a physiological channel alteration.
The computer modelling we used in this study has been used
by other groups to assess initially the hypothetical effects of
gene expression changes on cardiac electrophysiology and
we have used it as a similar first step in assessment but it is
acknowledged by our team that the computer modelling is an
initial step with the results needing confirmation using direct
electrophysiology testing. We hope that the results presented
here could be taken forward and further research could be
performed to assess these areas.
5. Conclusion
In dietary obesity, there are significant changes in the gene
expression of ion channels in the left ventricle, which may
predispose to arrhythmias. The changes may possibly reflect
a specific genotype relating to obesity that may need differing
treatments and clinical investigation compared to other
groups. As the prevalence of obesity continues to increase, the
observed genotype changes would be expected to correlate
with a growing number of patients with clinical arrhythmias.
Further studies are required to confirm the mRNA changes
with protein and electrophysiological measurements and to
elucidate the significance of these changes and the potential
for targeted treatment in obese patients.
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